SEC Form 4 · accession 0001246360-15-000261
NxStage Medical, Inc. · NXTM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Winifred L Swan
Officer — SVP and General Counsel
Period of report
Jan 13, 2015
Accepted (ET)
Jan 14, 2015 · 5:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001333170
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 13, 2015 | M | 666 | $0.00 | A | 19,354 | D | |
| Common Stock | Jan 13, 2015 | S | 666 | $18.35 | D | 18,688 | D | |
| Common Stock | Jan 14, 2015 | S | 500 | $18.44 | D | 18,188 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $6.84 | Jan 13, 2015 | M | 666 | D | Jan 20, 2005 | Jan 20, 2015 | Common Stock | 666 | 0 | D |
Explanation of responses
- F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2014.